Uniform Biological Material Transfer Agreement – MTA

Definitions

1. PROVIDER: Organization providing the ORIGINAL MATERIAL. The name and address of this party will be specified in an implementing letter.
2. PROVIDER SCIENTIST: The name and address of this party will be specified in an implementing letter.
3. RECIPIENT: Organization receiving the ORIGINAL MATERIAL. The name and address of this party will be specified in an implementing letter.
4. RECIPIENT SCIENTIST: The name and address of this party will be specified in an implementing letter.
5. ORIGINAL MATERIAL: The description of the material being transferred will be specified in an implementing letter.
6. MATERIAL: ORIGINAL MATERIAL, and PROGENY. The MATERIAL shall not include: (a) MODIFICATIONS, or (b) other substances created by the RECIPIENT through the use of the MATERIAL which are not MODIFICATIONS, PROGENY, or UNMODIFIED DERIVATIVES.
7. PROGENY: Unmodified descendant from the MATERIAL, such as virus from virus, cell from cell, or organism from organism, DNA/RNA duplicated by DNA/RNA supplied by the PROVIDER, purified or fractionated subsets of the ORIGINAL MATERIAL.
8. UNMODIFIED DERIVATIVES: Substances created by the RECIPIENT which constitute an unmodified functional subunit or product expressed by the ORIGINAL MATERIAL. Some examples include: proteins expressed by DNA/RNA supplied by the PROVIDER, or monoclonal antibodies secreted by a hybridoma cell line.
9. MODIFICATIONS: Substances created by the RECIPIENT which contain/incorporate the MATERIAL, and UNMODIFIED DERIVATIVES.
10. COMMERCIAL PURPOSES: The sale, lease, license, or other transfer of the MATERIAL or MODIFICATIONS to a for-profit organization. COMMERCIAL PURPOSES shall also include uses of the MATERIAL or MODIFICATIONS by any organization, including RECIPIENT, to perform contract research, to screen compound libraries, to produce or manufacture products for general sale, or to conduct research activities that result in any sale, lease, license, or transfer of the MATERIAL or MODIFICATIONS to a for-profit organization. However, industrially sponsored academic research shall not be considered a use of the MATERIAL or MODIFICATIONS for COMMERCIAL PURPOSES per se, unless any of the above conditions of this definition are met.
11. NONPROFIT ORGANIZATION(S): A university or other institution of higher education or an organization any nonprofit scientific or educational organization qualified under a nonprofit organization statute. As used herein, the term also includes government agencies.

Terms and Conditions of this Agreement

1. The PROVIDER retains ownership of the MATERIAL, including any MATERIAL contained or incorporated in MODIFICATIONS.

2. The RECIPIENT retains ownership of: (a) MODIFICATIONS (except that, the PROVIDER retains ownership rights to the MATERIAL included therein), and (b) those substances created through the use of the MATERIAL or MODIFICATIONS, but which are not PROGENY, UNMODIFIED DERIVATIVES or MODIFICATIONS (i.e., do not contain the ORIGINAL MATERIAL, PROGENY, UNMODIFIED DERIVATIVES). If either 2 (a) or 2 (b) results from the collaborative efforts of the PROVIDER and the RECIPIENT, joint ownership may be negotiated.

a) is to be used solely for teaching and academic research purposes;
b) will not be used in human subjects, in clinical trials, or for diagnostic purposes involving human subjects without the written consent of the PROVIDER;
c) is to be used only at the RECIPIENT organization and only in the RECIPIENT SCIENTIST's laboratory under the direction of the RECIPIENT SCIENTIST or others working under his/her direct supervision;
d) will not be transferred to anyone else outside the RECIPIENT organization without the prior written consent of the PROVIDER.

4. The RECIPIENT and the RECIPIENT SCIENTIST agree to refer to the PROVIDER any request for the MATERIAL from anyone other than those persons working under the RECIPIENT SCIENTIST's direct supervision. To the extent supplies are available, the PROVIDER or the PROVIDER SCIENTIST agrees to make the MATERIAL available, under a separate implementing letter to this Agreement or other agreement having terms consistent with the terms of this Agreement, to other scientists (at least those at NONPROFIT ORGANIZATION(S)) who wish to replicate the RECIPIENT SCIENTIST's research; provided that such other scientists reimburse the PROVIDER for any costs relating to the preparation and distribution of the MATERIAL.

a) The PROVIDER and/or the PROVIDER SCIENTIST shall have the right, without restriction, to distribute substances created by the PROVIDER through the use of the ORIGINAL MATERIAL only if those substances are not PROGENY, UNMODIFIED DERIVATIVES, or MODIFICATIONS.
b) Under a separate implementing letter to this Agreement (or an agreement at least as protective of the PROVIDER's rights), the RECIPIENT and/or the RECIPIENT SCIENTIST may distribute substances created by the RECIPIENT through the use of the ORIGINAL MATERIAL only if those substances are not PROGENY, UNMODIFIED DERIVATIVES, or MODIFICATIONS.
c) The PROVIDER and/or the PROVIDER SCIENTIST shall have the right, without restriction, to distribute MODIFICATIONS to NONPROFIT ORGANIZATION(S) for research and teaching purposes only.
d) The PROVIDER and/or the PROVIDER SCIENTIST shall have the right, without restriction, to distribute MATERIAL for COMMERCIAL PURPOSES. It is recognized by the PROVIDER that such COMMERCIAL PURPOSES may NOT require a commercial license from the RECIPIENT and the RECIPIENT has no obligation to grant a commercial license to its ownership interest in the MATERIAL. Nothing in this paragraph, however, shall prevent the PROVIDER from granting commercial licenses under the PROVIDER's intellectual property rights claiming such MATERIAL, or methods of their manufacture or their use.
e) The RECIPIENT and/or the RECIPIENT SCIENTIST shall have the right, without restriction, to distribute MODIFICATIONS for COMMERCIAL PURPOSES. It is recognized by the RECIPIENT that such COMMERCIAL PURPOSES may NOT require a commercial license from the PROVIDER and the PROVIDER has no obligation to grant a commercial license to its ownership interest in the MATERIAL incorporated in the MODIFICATIONS. Nothing in this paragraph, however, shall prevent the RECIPIENT from granting commercial licenses under the RECIPIENT's intellectual property rights claiming such MODIFICATIONS, or methods of their manufacture or their use.

6. The RECIPIENT acknowledges that the MATERIAL is or may be the subject of a patent application. Except as provided in this Agreement, no express or implied licenses or other rights are provided to the RECIPIENT under any patents, patent applications, trade secrets or other proprietary rights of the PROVIDER, including any altered forms of the MATERIAL made by the PROVIDER. In particular, no express or implied licenses or other rights are provided to use the MATERIAL, MODIFICATIONS, or any related patents of the PROVIDER for COMMERCIAL PURPOSES.

7. If the RECIPIENT desires to use or license the MATERIAL for COMMERCIAL PURPOSES, the RECIPIENT agrees, in advance of such use, to negotiate in good faith with the PROVIDER to establish the terms of a commercial license. It is understood by the RECIPIENT that the PROVIDER shall have no obligation to grant such a license to the RECIPIENT, and may grant exclusive or non-exclusive commercial licenses to others, or sell or assign all or part of the rights in the MATERIAL to any third party(ies), subject to any pre-existing rights held by others and obligations to the Federal Government.

8. If the PROVIDER desires to use or license the MODIFICATIONS for COMMERCIAL PURPOSES, the PROVIDER agrees, in advance of such use, to negotiate in good faith with the RECIPIENT to establish the terms of a commercial license. It is understood by the PROVIDER that the RECIPIENT shall have no obligation to grant such a license to the PROVIDER, and may grant exclusive or non-exclusive commercial licenses to others, or sell or assign all or part of the rights in the MODIFICATIONS to any third party(ies), subject to any pre-existing rights held by others and obligations to theGovernment.

9. The PROVIDER is free to file patent application(s) claiming inventions made by the PROVIDER through the use of the MODIFICATIONS but agrees to notify the RECIPIENT upon filing a patent application claiming MATERIAL or method(s) of manufacture or use(s) of the MATERIAL.

10. The RECIPIENT is free to file patent application(s) claiming inventions made by the RECIPIENT through the use of the MATERIAL but agrees to notify the PROVIDER upon filing a patent application claiming MODIFICATIONS or method(s) of manufacture or use(s) of the MATERIAL.

11. Any MATERIAL delivered pursuant to this Agreement is understood to be experimental in nature and may have hazardous properties. The PROVIDER MAKES NO REPRESENTATIONS AND EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED. THERE ARE NO EXPRESS OR IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR THAT THE USE OF THE MATERIAL WILL NOT INFRINGE ANY PATENT, COPYRIGHT, TRADEMARK, OR OTHER PROPRIETARY RIGHTS.

12. Except to the extent prohibited by law, the RECIPIENT assumes all liability for damages which may arise from its use, storage or disposal of the MATERIAL. The PROVIDER will not be liable to the RECIPIENT for any loss, claim or demand made by the RECIPIENT, or made against the RECIPIENT by any other party, due to or arising from the use of the MATERIAL by the RECIPIENT, except to the extent permitted by law when caused by the gross negligence or willful misconduct of the PROVIDER.

13. This agreement shall not be interpreted to prevent or delay publication of research findings resulting from the use of the MATERIAL or the MODIFICATIONS. The PROVIDER SCIENTIST agrees to provide appropriate acknowledgment of the source of the MODIFICATIONS in all publications. The RECIPIENT SCIENTIST agrees to provide appropriate acknowledgment of the source of the MATERIAL in all publications.

14. The PROVIDER agrees to use the MODIFICATIONS in compliance with all applicable statutes and regulations, including Public Health Service and National Institutes of Health regulations and guidelines such as, for example, those relating to research involving the use of animals or recombinant DNA. The RECIPIENT agrees to use the MATERIAL in compliance with all applicable statutes and regulations, including Public Health Service and National Institutes of Health regulations and guidelines such as, for example, those relating to research involving the use of animals or recombinant DNA.

i) if termination should occur under 15(a), the RECIPIENT shall be bound to the PROVIDER by the least restrictive terms applicable to the MATERIAL obtained from the then-available resources; and
ii) if termination should occur under 15(b) or (d) above, the RECIPIENT will discontinue its use of the MATERIAL and will, upon direction of the PROVIDER, return or destroy any remaining MATERIAL. The RECIPIENT, at its discretion, will also either destroy the MODIFICATIONS or remain bound by the terms of this agreement as they apply to MODIFICATIONS; and
iii) In the event the PROVIDER terminates this Agreement under 15( c) other than for breach of this Agreement or for cause such as an imminent health risk or patent infringement, the PROVIDER will defer the effective date of termination for a period of up to one year, upon request from the RECIPIENT, to permit completion of research in progress. Upon the effective date of termination, or if requested, the deferred effective date of termination, RECIPIENT will discontinue its use of the MATERIAL and will, upon direction of the PROVIDER, return or destroy any remaining MATERIAL. The RECIPIENT, at its discretion, will also either destroy the MODIFICATIONS or remain bound by the terms of this agreement as they apply to MODIFICATIONS.

16.Paragraphs 6, 11 and 12 shall survive termination.

17.The MATERIAL is provided at no cost, or with an optional transmittal fee solely to reimburse the PROVIDER for its preparation and distribution costs. If a fee is requested by the PROVIDER, the amount will be indicated in an implementing letter. Main Text Ends Here.

RECIPIENT: Kangma-Healthcode (Shanghai) Biotech Co. Ltd.
RECIPIENT SCIENTIST: Rongrong Zhan
RECIPIENT ADDRESS: Building 15, Lane 118 Furonghua Road, Shanghai 201321, CHINA
RECIPIENT TEL: 021-58086922
RECIPIENT EMAIL: customer@healthcodon.com

Protocol Specification

提示

阅读并同意隐私协议、MTA和使用条款后进行下一步!

Automatic Protein Purifcation Instrument Pruoto AutoPurifier-32- OurProteinFactory

Automatic Protein Purifcation Instrument Pruoto AutoPurifier-32

Product code

protn_D2Pi32Appc

19600.00

Size

Pruoto AutoPurifier 32 Channel

Pr Auto His-Monster Protein Auto Purification Kit - S

Pr Auto His-Monster Protein Auto Purification Kit - S2

Pr Auto His-Monster Protein Auto Purification Kit - M

Pr Auto His-Monster Protein Auto Purification Kit - M2

Quantity

All of our products are guaranteed with with the 30-day return/refund policy. Please shop with 100% satisfaction.

Free shipping for order over $1000 USD.

Add To Cart

Order Now

Successfully added to shopping cart

Document

释放无穷的纯化潜力

采用Pruoto Auto Purifier-32高通量自动蛋白纯化仪

体验不一样的速度和便捷

方寸之间，凝聚智慧

创新科技，打造自动纯化。
仅需占用428*396mm工作面积，
更大化利用宝贵的实验室桌面。

轻松实现多组目标蛋白

32通道，单次运行可同时纯化32组目标蛋白。无
需人工干预，自动完成所有试验流程，实验结果稳
定可靠，效率提高十倍以上！

高质量

硬实力组合，经得起时间考验

专用Monster Beads™微米磁珠，高效结合目标蛋白，蛋白纯度可达98％，得率每组可达0.5-2.5 mg。

凝聚蛋白质工厂雄厚技术经验与
积累，专为实现自动化蛋白纯化研
究而开发。

片刻间完成快速纯化

卓越的速度，Pruoto AutoPurifier-32

有实力，就是不一样

全球首款

全球首款用于无细胞蛋白质合成的高通量纯化设备

用于ProteinFactory无细胞合成蛋白质纯化，纯化性能优异，具有快速可靠处理大量样品的优势。
高度自动化集成，缩短手动样品制备时间、降低成本和增加通量来提高您的实验生产率。

可用于多种标签Tag的特异性纯化

配合PrAuto™蛋白自动纯化试剂盒，可用于多种标签Tag的特异性纯化，包括His，GST，Biotin，
Fc，MBP等。纯化后的蛋白可直接应用于下一步的酶切、鉴定以及疾病诊断等。

智能控制与操作界面

出色的图形化界面交互

搭载微电脑控制系统，无需外接电脑。10吋彩色触摸面板，实时显示温度、实验进程，及剩余实验时
间等信息。成套自动化解决方案，可直接在仪器操作界面自由编辑纯化程序，有效提高工作效率。

采用Pruoto Auto Purifier-32高通量自动蛋白纯化仪

纯化效果更均一，更高纯度，更方便

使用Pruoto Auto Purifier-32 高通量自动蛋白纯化仪纯化后，最终得到的纯化效果显示出，用自动
化设备提取的蛋白，更均一，更高纯度，更方便。

采用Pruoto Auto Purifier-32高通量自动蛋白纯化仪纯化后的EGFP蛋白

EGFP protein purified by Pruoto Auto Purifier-32 high-throughput automatic protein purifier.

蛋白自动纯化试剂盒

高效纯化组合

PrAuto Protein Auto Purification Kit蛋白自动纯化试剂盒，专为ProteinFactory蛋白表达而设计。16独立通道，每次
运行可纯化0.5-2.5 mg蛋白质，8-40 mg蛋白质纯化总量。配合ProteinFactory蛋白质工厂体外合成系统，和Pruoto多通
道自动蛋白纯化仪，在10分钟内即可完成16-96组目标蛋白的快速、高效纯化，让您的目标蛋白质纯化更容易。

PrAuto™ His-Monster

蛋白自动纯化试剂盒 96深孔板装 (磁珠法)
PrAuto™ GST-Monster

蛋白自动纯化试剂盒 96深孔板装 (磁珠法)
PrAuto™ Biotin-Monster

蛋白自动纯化试剂盒 96深孔板装 (磁珠法)
PrAuto™ MBP-Monster

蛋白自动纯化试剂盒 96深孔板装 (磁珠法)
PrAuto™ Protein A-Monster

蛋白自动纯化试剂盒 96深孔板装 (磁珠法)
PrAuto™ Protein G-Monster

蛋白自动纯化试剂盒 96深孔板装 (磁珠法)
PrAuto™ NBP Monster

蛋白自动纯化试剂盒 96深孔板装 (磁珠法)

PrAuto™ GST-Monster
PrAuto™ Biotin-Monster
PrAuto™ MBP-Monster
PrAuto™ Protein A-Monster
PrAuto™ Protein G-Monster
PrAuto™ NBP Monster etc.

全自动，即刻启程

32通道
纯度高达98％
10min自动提取

全球首款无细胞蛋白质合成纯化设备
可用于多种标签Tag的特异性纯化

10吋彩色触摸面板
仅占428*396mm工作面积
微米级Monster Beads™

技术参数

高通量自动蛋白纯化仪

产品型号	Pruoto AutoPurifier-32A
产品编码	protn_D2Pi32Appc
提取通量	1~32
磁棒数量	32
孔板类型	96孔深孔板
处理体积	30 μL~1000 μL
磁珠回收率	大于95%
提纯孔间差	CV<5%
搅拌混合	慢、中、快多档可编辑设置
提取时间	平均10分钟/次(由项目决定)
屏幕尺寸	10吋
操作界面	10吋中英文彩色液晶显示+触控操作
内部程序	程序可以自由编辑可以存储204个程序
流程管理	可进行编程，新建流程、编辑流程、删除流程等
安全控制	开门时自动暂停程序
污染控制	循环风路+过滤系统+紫外消毒
震荡混合	可编辑不同需求的混合方式
裂解/洗脱加热温度	室温至 +99℃
数据储存	可储存，内置储存设备
工作温度	+10 ~ +40℃
工作湿度	10~90%相对湿度(无冷凝)
电源输入	AC 220V，50Hz
功率	300W
外形尺寸	LWH=428396397mm
毛重	25kg
使用期限	6年

蛋白自动纯化试剂盒96深孔板装(磁珠法)

产品名称	PrAuto™ Protein Auto Purification Kit 96 DeepWell Plate (Magnetic Beads)
产品规格	S / M
通道	16
目标蛋白载量	0.5 mg (S)，2.5 mg (M)
上样量	1 mL (S)，5 mL (M)
磁珠类型	PrAuto™ His-Monster PrAuto™ GST-Monster PrAuto™ Biotin-Monster PrAuto™ MBP-Monster PrAuto™ Protein A-Monster PrAuto™ Protein G-Monster PrAuto™ NBP Monster etc.

注释

以上页面中的出现的产品图片仅作示意，实物产品效果(包括但不限于外观、颜色、尺寸)可能略有差异，请以实物为准。
实际使用中可能因产品个体差异、使用条件和环境因素不同而略有不同，请以实际使用的情况为准。
由于产品批次和生产供应因素实时变化，为尽可能提供准确的产品信息、规格参数、产品特性，OurProteinFactory可能实时调整和修订以上
页面中的文字表述、图片效果等内容，以求与实际产品性能规格、指数、零部件等信息相匹配。如遇确有进行上述修改和调整必要的情形，恕不专门通知。

FOOT

More ways to contact,Building #12-15, Furonghua Road, Pudong District, Shanghai, China Zip: 200120， please call +1-800-955-3390or+86-400-770-5500Monday to Sunday 0:00-24:00